| Anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG00027 events26 affected8,212 at risk
- EG00119 events17 affected8,280 at risk
|
| Anaemia megaloblastic | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Anaemia of chronic disease | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Coagulopathy | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Disseminated intravascular coagulation | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Febrile neutropenia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Haemorrhagic diathesis | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hypereosinophilic syndrome | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hypochromic anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lymphopenia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Nephrogenic anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Normochromic normocytic anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Pancytopenia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pernicious anaemia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Acute left ventricular failure | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Adams-Stokes syndrome | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG000116 events106 affected8,212 at risk
- EG00198 events89 affected8,280 at risk
|
| Angina unstable | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00079 events63 affected8,212 at risk
- EG00148 events44 affected8,280 at risk
|
| Aortic valve stenosis | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Arteriospasm coronary | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00090 events76 affected8,212 at risk
- EG00185 events78 affected8,280 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00013 events11 affected8,212 at risk
- EG00125 events22 affected8,280 at risk
|
| Atrial septal defect acquired | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Atrioventricular block | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00013 events13 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Atrioventricular block first degree | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events5 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Bifascicular block | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bradyarrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bradycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00011 events11 affected8,212 at risk
- EG00115 events14 affected8,280 at risk
|
| Bundle branch block | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cardiac aneurysm | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00024 events24 affected8,212 at risk
- EG00122 events21 affected8,280 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Cardiac failure chronic | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00022 events21 affected8,212 at risk
- EG00130 events30 affected8,280 at risk
|
| Cardiac fibrillation | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Cardiac valve disease | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cardiogenic shock | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Cardiopulmonary failure | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cardiovascular disorder | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cardiovascular insufficiency | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Congestive cardiomyopathy | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Cor pulmonale | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00019 events18 affected8,212 at risk
- EG00117 events17 affected8,280 at risk
|
| Coronary artery insufficiency | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Coronary artery occlusion | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Diastolic dysfunction | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypertensive heart disease | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypertrophic cardiomyopathy | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Intracardiac thrombus | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events6 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events2 affected8,280 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00011 events11 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Nodal arrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Palpitations | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Pericarditis | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pulseless electrical activity | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Right ventricular dysfunction | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Sick sinus syndrome | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events14 affected8,212 at risk
- EG00110 events10 affected8,280 at risk
|
| Sinoatrial block | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Sinus arrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Sinus bradycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG00110 events9 affected8,280 at risk
|
| Systolic dysfunction | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tachyarrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events2 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Torsade de pointes | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Trifascicular block | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Ventricular hypokinesia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ventricular tachyarrhythmia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA 15.1 | Systematic Assessment | | - EG00016 events11 affected8,212 at risk
- EG00117 events16 affected8,280 at risk
|
| Deafness | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Meniere's disease | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Sudden hearing loss | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| Tympanic membrane perforation | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG00010 events10 affected8,212 at risk
- EG00116 events16 affected8,280 at risk
|
| Vertigo positional | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Vestibular disorder | Ear and labyrinth disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Adrenal insufficiency | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Goitre | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Hypercorticoidism | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hyperparathyroidism primary | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Hypothyroidism | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Toxic nodular goitre | Endocrine disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Angle closure glaucoma | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cataract | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG00015 events13 affected8,212 at risk
- EG0019 events7 affected8,280 at risk
|
| Cataract cortical | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diabetic retinopathy | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0017 events6 affected8,280 at risk
|
| Diplopia | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Glaucoma | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Macular oedema | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Optic ischaemic neuropathy | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Retinal artery occlusion | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Retinal detachment | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Retinal haemorrhage | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Retinal ischaemia | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ulcerative keratitis | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vision blurred | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Vitreous haemorrhage | Eye disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Abdominal adhesions | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Abdominal hernia obstructive | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events13 affected8,212 at risk
- EG00117 events17 affected8,280 at risk
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Abdominal strangulated hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abdominal wall haematoma | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Anal fistula | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Anal polyp | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Colitis ulcerative | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Colonic polyp | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Colonic pseudo-obstruction | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Crohn's disease | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diabetic gastroparesis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diaphragmatic hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00015 events15 affected8,212 at risk
- EG00113 events12 affected8,280 at risk
|
| Diverticular perforation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diverticulitis intestinal haemorrhagic | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diverticulum intestinal | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Diverticulum oesophageal | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Duodenal perforation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Duodenal ulcer perforation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Dyskinesia oesophageal | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Enteritis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Enterovesical fistula | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Epigastric discomfort | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Faecaloma | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Femoral hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Food poisoning | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastric antral vascular ectasia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastric haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00012 events11 affected8,212 at risk
- EG00115 events15 affected8,280 at risk
|
| Gastritis atrophic | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastritis erosive | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastritis haemorrhagic | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastrointestinal angiodysplasia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00025 events18 affected8,212 at risk
- EG00115 events15 affected8,280 at risk
|
| Gastrointestinal hypomotility | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastrointestinal inflammation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Gastrointestinal telangiectasia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastrointestinal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastrointestinal vascular malformation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Gingival bleeding | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Haematochezia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Haemorrhagic erosive gastritis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Inflammatory bowel disease | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Inguinal hernia, obstructive | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Intestinal ischaemia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Intestinal perforation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Intestinal polyp haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Large intestinal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Large intestine perforation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lower gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Mallory-Weiss syndrome | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Megacolon | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Mesenteric artery stenosis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Mesenteric artery thrombosis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Mesenteric vascular insufficiency | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Oesophageal fibrosis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Oesophageal obstruction | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Oesophageal spasm | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Oesophageal stenosis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Oesophageal varices haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Oesophagitis ulcerative | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Omental infarction | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pancreatic duct dilatation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pancreatic mass | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events12 affected8,212 at risk
- EG00119 events18 affected8,280 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0015 events4 affected8,280 at risk
|
| Pancreatitis chronic | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Pancreatolithiasis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rectal polyp | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Rectal prolapse | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Reflux gastritis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Retroperitoneal fibrosis | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Small intestinal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events4 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Small intestinal perforation | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Tongue disorder | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Umbilical hernia, obstructive | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00010 events9 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Varices oesophageal | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Adverse drug reaction | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Application site pain | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Asthenia | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Catheter site haemorrhage | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Chest discomfort | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Chest pain | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG00010 events10 affected8,212 at risk
- EG00114 events14 affected8,280 at risk
|
| Cyst | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Death | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Device battery issue | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Device breakage | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Device damage | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Device dislocation | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Device failure | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Device lead damage | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Device malfunction | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Exercise tolerance decreased | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Fatigue | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Feeling cold | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Foaming at mouth | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gait disturbance | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| General physical health deterioration | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| General symptom | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Generalised oedema | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hernia | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hernia obstructive | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypothermia | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Impaired healing | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Implant site haematoma | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Inflammation | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Ischaemic ulcer | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lipogranuloma | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Malaise | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Medical device complication | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Multi-organ disorder | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Multi-organ failure | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Necrobiosis | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Necrosis | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG000131 events109 affected8,212 at risk
- EG001125 events108 affected8,280 at risk
|
| Oedema peripheral | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Organ failure | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pain | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Polyp | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pyrexia | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Spinal pain | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Systemic inflammatory response syndrome | General disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Bile duct obstruction | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Biliary colic | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Biliary dyskinesia | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Biliary polyp | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cholangitis acute | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00012 events10 affected8,212 at risk
- EG00113 events13 affected8,280 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events14 affected8,212 at risk
- EG00122 events22 affected8,280 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00028 events27 affected8,212 at risk
- EG00127 events26 affected8,280 at risk
|
| Drug-induced liver injury | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gallbladder disorder | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gallbladder perforation | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Hepatic function abnormal | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hepatic ischaemia | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hepatic lesion | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hepatitis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hydrocholecystis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ischaemic hepatitis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Liver disorder | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Portal vein thrombosis | Hepatobiliary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Allergy to venom | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Anaphylactic shock | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Autoimmune disorder | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cryoglobulinaemia | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Hypersensitivity | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Sarcoidosis | Immune system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abdominal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Abscess limb | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Abscess soft tissue | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Acarodermatitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Acinetobacter bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Acute sinusitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Adenovirus infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Anal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Appendicitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0009 events9 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Appendicitis perforated | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Arthritis bacterial | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Arthritis infective | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Bacterial infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bacterial sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bone abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Breast cellulitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Breast infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bronchiolitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bronchitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00035 events35 affected8,212 at risk
- EG00123 events23 affected8,280 at risk
|
| Bronchitis viral | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bronchopneumonia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0009 events8 affected8,212 at risk
- EG00110 events10 affected8,280 at risk
|
| Bursitis infective | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Campylobacter infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Carbuncle | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cellulitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00070 events65 affected8,212 at risk
- EG00170 events58 affected8,280 at risk
|
| Cellulitis gangrenous | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cellulitis of male external genital organ | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cellulitis staphylococcal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervicitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Chest wall abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cholangitis suppurative | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cholecystitis infective | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Clostridial infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Clostridium difficile sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Creutzfeldt-Jakob disease | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cystitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events2 affected8,280 at risk
|
| Dengue fever | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Device related infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Diabetic foot infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG00111 events10 affected8,280 at risk
|
| Diabetic gangrene | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0019 events9 affected8,280 at risk
|
| Diarrhoea infectious | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Diverticulitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00013 events10 affected8,212 at risk
- EG00111 events10 affected8,280 at risk
|
| Ear infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Emphysematous cystitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Empyema | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Endocarditis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Endocarditis enterococcal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Endophthalmitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Enterobacter bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Enterobacter infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Enterobacter pneumonia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Enterococcal bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Enterococcal sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Enterocolitis infectious | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Erysipelas | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Escherichia bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Escherichia infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Escherichia sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Escherichia urinary tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Febrile infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Furuncle | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gallbladder abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gangrene | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00017 events16 affected8,212 at risk
- EG00123 events22 affected8,280 at risk
|
| Gastric ulcer helicobacter | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00017 events17 affected8,212 at risk
- EG00129 events28 affected8,280 at risk
|
| Gastroenteritis clostridial | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastroenteritis norovirus | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastroenteritis shigella | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastroenteritis viral | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Graft infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Groin abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Groin infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| H1N1 influenza | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| HIV infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Helicobacter infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hepatitis B | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Herpes zoster ophthalmic | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Implant site cellulitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Incision site infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Infected dermal cyst | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Infected fistula | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Infected skin ulcer | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0009 events8 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Infectious peritonitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Infectious thyroiditis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Influenza | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Intestinal gangrene | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Klebsiella infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Labyrinthitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Liver abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lobar pneumonia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG00116 events16 affected8,280 at risk
|
| Localised infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00011 events11 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0016 events4 affected8,280 at risk
|
| Ludwig angina | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lung infection pseudomonal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lyme disease | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Mastoiditis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Mediastinitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Meningitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Necrotising fasciitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Oesophageal candidiasis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Orchitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Osteomyelitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00025 events24 affected8,212 at risk
- EG00123 events18 affected8,280 at risk
|
| Osteomyelitis chronic | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Otitis externa | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Parametritis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pelvic abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Peridiverticular abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Perihepatic abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Perineal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Perinephric abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Periorbital cellulitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Perirectal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Peritoneal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Peritonitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Peritonitis bacterial | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pilonidal cyst | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumococcal bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumococcal sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumocystis jiroveci infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumonia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG000127 events118 affected8,212 at risk
- EG001168 events151 affected8,280 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumonia chlamydial | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumonia fungal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumonia legionella | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumonia mycoplasmal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumonia pneumococcal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumonia staphylococcal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumonia viral | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Post procedural infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Post procedural sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Postoperative abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00010 events9 affected8,212 at risk
- EG0019 events8 affected8,280 at risk
|
| Prostatic abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pseudomonal sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pulmonary sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG00111 events11 affected8,280 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0016 events5 affected8,280 at risk
|
| Rectal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Renal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Respiratory tract infection viral | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Retroperitoneal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rhinitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00022 events20 affected8,212 at risk
- EG00121 events21 affected8,280 at risk
|
| Sepsis syndrome | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Septic shock | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0009 events9 affected8,212 at risk
- EG00111 events11 affected8,280 at risk
|
| Sinusitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Skin bacterial infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Skin infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Staphylococcal bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events3 affected8,280 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Staphylococcal skin infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Streptococcal bacteraemia | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Streptococcal urinary tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Subcutaneous abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Subdiaphragmatic abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Syphilis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Testicular abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Thrombophlebitis septic | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tracheobronchitis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Typhoid fever | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0018 events7 affected8,280 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG00050 events49 affected8,212 at risk
- EG00142 events40 affected8,280 at risk
|
| Urinary tract infection bacterial | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Urinary tract infection staphylococcal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Urosepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG00110 events10 affected8,280 at risk
|
| Vaginal abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Viral infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Vulval abscess | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Wound infection | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Wound infection staphylococcal | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Wound sepsis | Infections and infestations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Accident | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Acetabulum fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Allergic transfusion reaction | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Anastomotic ulcer haemorrhage | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Arteriovenous fistula site complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Arteriovenous graft site haematoma | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bone fissure | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Brachial plexus injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Burns second degree | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Burns third degree | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Carbon monoxide poisoning | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cartilage injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Chest injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Contrast media reaction | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Cystitis radiation | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Face injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Feeding tube complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG00110 events10 affected8,280 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG00010 events10 affected8,212 at risk
- EG00115 events13 affected8,280 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Forearm fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Foreign body | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Fractured coccyx | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Graft complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Graft dysfunction | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Graft thrombosis | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Heart injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG00010 events10 affected8,212 at risk
- EG0019 events8 affected8,280 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0019 events9 affected8,280 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ligament rupture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Limb traumatic amputation | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Meniscus lesion | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Multiple drug overdose intentional | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Near drowning | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Patella fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Peripheral artery restenosis | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Periprosthetic fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumothorax traumatic | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Post concussion syndrome | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Post embolisation syndrome | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Post procedural bile leak | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Post procedural complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Post procedural discharge | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Post procedural haematuria | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0006 events5 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Postoperative fever | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Postoperative hernia | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Postoperative renal failure | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Postoperative thoracic procedure complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Postoperative wound complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Pubis fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Scapula fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Seroma | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Skeletal injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Skull fractured base | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Splenic haematoma | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Splenic rupture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0019 events9 affected8,280 at risk
|
| Subdural haemorrhage | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Suture related complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tendon injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tooth fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Toxicity to various agents | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Tracheal injury | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Traumatic haematoma | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Traumatic intracranial haemorrhage | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Traumatic ulcer | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Vascular graft complication | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Vascular graft thrombosis | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Wound haemorrhage | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Wound necrosis | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Wound secretion | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Arteriogram coronary | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Aspartate aminotransferase increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Blood bilirubin increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Blood creatine phosphokinase increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Blood creatinine increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Blood glucose increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Blood potassium increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Blood pressure abnormal | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Blood pressure increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| C-reactive protein increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cardiac stress test abnormal | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Chest X-ray abnormal | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Clostridium test positive | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Coagulation factor VIII level increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Coagulation test abnormal | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ejection fraction decreased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Electrocardiogram abnormal | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Haemoglobin decreased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Heart rate increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| International normalised ratio increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Liver function test abnormal | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Prostatic specific antigen increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Transaminases increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Troponin increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Urine albumin/creatinine ratio increased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Weight decreased | Investigations | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG00018 events17 affected8,212 at risk
- EG00113 events13 affected8,280 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events13 affected8,212 at risk
- EG00114 events12 affected8,280 at risk
|
| Diabetes mellitus inadequate control | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG00013 events11 affected8,212 at risk
- EG00112 events10 affected8,280 at risk
|
| Diabetic complication | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events5 affected8,212 at risk
- EG00110 events8 affected8,280 at risk
|
| Electrolyte imbalance | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Failure to thrive | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Fluid overload | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Fluid retention | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG00062 events58 affected8,212 at risk
- EG00155 events51 affected8,280 at risk
|
| Hyperglycaemic hyperosmolar nonketotic syndrome | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG00015 events13 affected8,212 at risk
- EG00117 events17 affected8,280 at risk
|
| Hyperosmolar state | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events7 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Hypovolaemia | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Ketoacidosis | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Lactic acidosis | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Malnutrition | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Obesity | Metabolism and nutrition disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Articular calcification | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG00010 events10 affected8,212 at risk
- EG0019 events9 affected8,280 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Carpal collapse | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Diabetic amyotrophy | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Dupuytren's contracture | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Exostosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Extraskeletal ossification | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Fasciitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Fracture nonunion | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gouty arthritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hip deformity | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Inguinal mass | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Intervertebral disc disorder | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0015 events4 affected8,280 at risk
|
| Intervertebral disc displacement | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events13 affected8,212 at risk
- EG00110 events9 affected8,280 at risk
|
| Joint ankylosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Joint stiffness | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Mobility decreased | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Monarthritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG00035 events32 affected8,212 at risk
- EG00123 events23 affected8,280 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Myopathy | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Myositis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Neuropathic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Osteitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG00042 events40 affected8,212 at risk
- EG00151 events49 affected8,280 at risk
|
| Osteochondritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Osteochondrosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Osteolysis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Osteoporotic fracture | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Pathological fracture | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Polymyositis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Scoliosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Spinal disorder | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Spondylitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Synovial cyst | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Synovitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Tenosynovitis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Vertebral column mass | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vertebral foraminal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Abdominal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Adenocarcinoma of the cervix | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Adenocarcinoma pancreas | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Adenoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Adrenal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Angiocentric lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00057 events42 affected8,212 at risk
- EG00158 events52 affected8,280 at risk
|
| Basosquamous carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Benign neoplasm of bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Benign neoplasm of choroid | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Benign ovarian tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Benign renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Benign salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bile duct cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0009 events9 affected8,212 at risk
- EG00113 events12 affected8,280 at risk
|
| Bladder cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Bladder cancer stage II | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Bladder transitional cell carcinoma stage II | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Blast crisis in myelogenous leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bone neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Brain cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Breast cancer female | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00012 events12 affected8,212 at risk
- EG00110 events10 affected8,280 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Burkitt's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Carcinoid tumour of the gastrointestinal tract | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Central nervous system lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervix carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Choroid melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Chronic lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Chronic myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events2 affected8,280 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00018 events18 affected8,212 at risk
- EG00113 events13 affected8,280 at risk
|
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events3 affected8,280 at risk
|
| Colon neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Colorectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Diffuse large B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Endometrial cancer stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gallbladder cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00011 events9 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Gastric cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastric neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastrointestinal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastrointestinal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Gastrointestinal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Gastrointestinal tract adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Haemangioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Head and neck cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hepatic cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hepatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hepatic neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Hepatic neoplasm malignant recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hodgkin's disease nodular sclerosis stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Keratoacanthoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Laryngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Laryngeal cancer stage I | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Leiomyosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lentigo maligna | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lip neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Liposarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Lung adenocarcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lung adenocarcinoma stage III | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Lung carcinoma cell type unspecified recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lung carcinoma cell type unspecified stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lung carcinoma cell type unspecified stage III | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00016 events15 affected8,212 at risk
- EG00120 events19 affected8,280 at risk
|
| Lung squamous cell carcinoma stage II | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lung squamous cell carcinoma stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0009 events9 affected8,212 at risk
- EG00111 events11 affected8,280 at risk
|
| Malignant melanoma in situ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Malignant palate neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Malignant peritoneal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Malignant urinary tract neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Mesothelioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Mesothelioma malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Metastases to lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Metastases to peritoneum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Metastatic bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Metastatic gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Monoclonal gammopathy | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Multiple myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Myeloproliferative disorder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Neuroendocrine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Non-Hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ocular neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Oesophageal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ovarian adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ovarian cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ovarian fibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ovarian neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pancreatic neuroendocrine tumour metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Plasmacytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Polycythaemia vera | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00034 events34 affected8,212 at risk
- EG00143 events41 affected8,280 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Prostate cancer stage II | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Prostate cancer stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Prostatic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rectal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Renal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Renal cell carcinoma stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Retroperitoneal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Rhabdomyosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Sarcoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Sinonasal papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Small cell lung cancer stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Small intestine carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG00032 events30 affected8,212 at risk
- EG00119 events18 affected8,280 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Superficial spreading melanoma stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Testis cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Thyroid adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Thyroid neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0007 events6 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Uterine cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vascular neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Amnesia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Amyotrophic lateral sclerosis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Aphasia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Arachnoid cyst | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ataxia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Balance disorder | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Basal ganglia haemorrhage | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Brain injury | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Brain mass | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Brain stem haemorrhage | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Carotid arteriosclerosis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Carotid artery aneurysm | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Carotid artery disease | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events3 affected8,280 at risk
|
| Carotid artery occlusion | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG00011 events11 affected8,212 at risk
- EG00129 events29 affected8,280 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| Cerebral arteriosclerosis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cerebral circulatory failure | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Cerebral infarction | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cerebral ischaemia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cerebral microangiopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG00014 events14 affected8,212 at risk
- EG00112 events12 affected8,280 at risk
|
| Cerebrovascular disorder | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Cerebrovascular insufficiency | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervical myelopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cervical root pain | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervicobrachial syndrome | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Coma | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Complex partial seizures | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Convulsion | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Dementia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events2 affected8,280 at risk
|
| Dementia Alzheimer's type | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Demyelinating polyneuropathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diabetic encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Diabetic neuropathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0017 events7 affected8,280 at risk
|
| Dizziness | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG00011 events10 affected8,212 at risk
- EG00116 events16 affected8,280 at risk
|
| Dysarthria | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Encephalitis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Encephalomalacia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Epilepsy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events7 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Fahr's disease | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Guillain-Barre syndrome | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Haemorrhage intracranial | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Headache | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Hemiplegia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hemisensory neglect | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hepatic encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hydrocephalus | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypertensive encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hypoxic-ischaemic encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| IIIrd nerve paresis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| IVth nerve paralysis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Intraventricular haemorrhage | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ischaemic neuropathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Lacunar infarction | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Mental impairment | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Metabolic encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Migraine | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Monoplegia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Movement disorder | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Myasthenia gravis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Nerve root compression | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Neuralgia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Neurological symptom | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Occipital neuralgia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Optic neuritis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Orthostatic intolerance | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Parkinson's disease | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Parkinsonism | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Presyncope | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Radicular pain | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Radicular syndrome | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Sciatica | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Sensory disturbance | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Speech disorder | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Spinal cord infarction | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Subarachnoid haemorrhage | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Syncope | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG00033 events32 affected8,212 at risk
- EG00139 events37 affected8,280 at risk
|
| Tension headache | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Thalamus haemorrhage | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Toxic encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG00064 events60 affected8,212 at risk
- EG00149 events48 affected8,280 at risk
|
| Ulnar nerve palsy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Uraemic encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| VIIth nerve paralysis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Vascular dementia | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vascular encephalopathy | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vertebral artery stenosis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vertebrobasilar insufficiency | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Vocal cord paralysis | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| White matter lesion | Nervous system disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Adjustment disorder | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Adjustment disorder with depressed mood | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Agitation | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Alcoholism | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Anxiety | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Bipolar disorder | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0018 events7 affected8,280 at risk
|
| Delirium | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Depression | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events6 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Drug abuse | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hallucination | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Insomnia | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Major depression | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0018 events7 affected8,280 at risk
|
| Psychosomatic disease | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Psychotic disorder | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Stress | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Suicidal ideation | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Acute prerenal failure | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Azotaemia | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Bladder outlet obstruction | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Calculus bladder | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Calculus ureteric | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events7 affected8,212 at risk
- EG0017 events5 affected8,280 at risk
|
| Calculus urinary | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Cystitis haemorrhagic | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Cystitis noninfective | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diabetic nephropathy | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Glomerulonephritis membranoproliferative | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Glomerulonephritis membranous | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0016 events5 affected8,280 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lupus nephritis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00011 events11 affected8,212 at risk
- EG00116 events13 affected8,280 at risk
|
| Nephropathy | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Nephropathy toxic | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Nephrotic syndrome | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Renal artery stenosis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00020 events20 affected8,212 at risk
- EG00123 events23 affected8,280 at risk
|
| Renal failure acute | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00071 events65 affected8,212 at risk
- EG00189 events80 affected8,280 at risk
|
| Renal failure chronic | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00018 events17 affected8,212 at risk
- EG00119 events18 affected8,280 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG00025 events24 affected8,212 at risk
- EG00125 events22 affected8,280 at risk
|
| Renal infarct | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Renal mass | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Renal tubular necrosis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Stress urinary incontinence | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Tubulointerstitial nephritis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ureteric stenosis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Urethral stenosis | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0016 events5 affected8,280 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Urinary incontinence | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Urinary tract obstruction | Renal and urinary disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Acquired hydrocele | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Acquired phimosis | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Balanitis | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG00013 events13 affected8,212 at risk
- EG00113 events13 affected8,280 at risk
|
| Breast mass | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Cervical polyp | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Colpocele | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Dysfunctional uterine bleeding | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Endometrial hyperplasia | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Epididymitis | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Metrorrhagia | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Prostatic obstruction | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Prostatomegaly | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Rectocele | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Testicular cyst | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Uterine haemorrhage | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Uterine polyp | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events1 affected8,280 at risk
|
| Uterovaginal prolapse | Reproductive system and breast disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Acute lung injury | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG00112 events12 affected8,280 at risk
|
| Apnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events6 affected8,212 at risk
- EG00120 events15 affected8,280 at risk
|
| Atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Bullous lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00079 events53 affected8,212 at risk
- EG00188 events71 affected8,280 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00024 events24 affected8,212 at risk
- EG00119 events18 affected8,280 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0004 events4 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Emphysema | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0019 events8 affected8,280 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hydrothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hypercapnia | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events4 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Laryngeal stenosis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Lung consolidation | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Lung infiltration | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Nasal congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Nasal obstruction | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Nasal septum deviation | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Nocturnal dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events2 affected8,280 at risk
|
| Pharyngeal hypertrophy | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pharyngeal inflammation | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0009 events8 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG00110 events10 affected8,280 at risk
|
| Pneumonitis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Pulmonary congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00010 events10 affected8,212 at risk
- EG00111 events11 affected8,280 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0015 events3 affected8,280 at risk
|
| Pulmonary haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events7 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Pulmonary sarcoidosis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pulmonary toxicity | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Reflux laryngitis | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Respiratory arrest | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Respiratory disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG00013 events11 affected8,212 at risk
- EG00110 events9 affected8,280 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events6 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Snoring | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Status asthmaticus | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Vocal cord polyp | Respiratory, thoracic and mediastinal disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Actinic keratosis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Dermatitis contact | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Diabetic foot | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG00025 events23 affected8,212 at risk
- EG00124 events22 affected8,280 at risk
|
| Diabetic ulcer | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Drug eruption | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Dry gangrene | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Dyshidrosis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Ecchymosis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Erythema | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hyperhidrosis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Keloid scar | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Leukocytoclastic vasculitis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Neurodermatitis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Neuropathic ulcer | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Night sweats | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Panniculitis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Pemphigoid | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Pruritus | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Purpura | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Scar pain | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Skin fibrosis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Skin necrosis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Skin reaction | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG00024 events22 affected8,212 at risk
- EG00122 events21 affected8,280 at risk
|
| Stasis dermatitis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Stevens-Johnson syndrome | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Subcutaneous emphysema | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Toxic epidermal necrolysis | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Coronary revascularisation | Surgical and medical procedures | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Percutaneous coronary intervention | Surgical and medical procedures | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Accelerated hypertension | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events8 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Aortic calcification | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Aortic occlusion | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0007 events7 affected8,212 at risk
- EG0014 events4 affected8,280 at risk
|
| Arterial insufficiency | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Arterial occlusive disease | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0005 events5 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Arteriovenous fistula | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Blood pressure inadequately controlled | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0009 events9 affected8,212 at risk
- EG0018 events8 affected8,280 at risk
|
| Diabetic macroangiopathy | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Embolism venous | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Extremity necrosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Femoral artery embolism | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Femoral artery occlusion | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0008 events7 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Granulomatosis with polyangiitis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Haematoma | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0015 events5 affected8,280 at risk
|
| Haemorrhage | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Haemorrhagic infarction | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Hypertension | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00033 events30 affected8,212 at risk
- EG00132 events29 affected8,280 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00017 events16 affected8,212 at risk
- EG00118 events17 affected8,280 at risk
|
| Hypertensive emergency | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Hypoperfusion | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Hypotension | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00018 events17 affected8,212 at risk
- EG00122 events19 affected8,280 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Iliac artery occlusion | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00011 events10 affected8,212 at risk
- EG00111 events10 affected8,280 at risk
|
| Necrosis ischaemic | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0006 events5 affected8,212 at risk
- EG0016 events6 affected8,280 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00049 events43 affected8,212 at risk
- EG00125 events24 affected8,280 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0003 events3 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Peripheral artery dissection | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Peripheral artery stenosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0009 events8 affected8,212 at risk
- EG00120 events18 affected8,280 at risk
|
| Peripheral artery thrombosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Peripheral embolism | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Peripheral ischaemia | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00046 events39 affected8,212 at risk
- EG00135 events24 affected8,280 at risk
|
| Peripheral vascular disorder | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG00022 events20 affected8,212 at risk
- EG00124 events21 affected8,280 at risk
|
| Shock | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Subclavian artery occlusion | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Subclavian artery stenosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events2 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Thrombosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0013 events3 affected8,280 at risk
|
| Varicose vein | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0012 events2 affected8,280 at risk
|
| Vascular occlusion | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|
| Vascular stenosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Vasculitis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Venous insufficiency | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0001 events1 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Venous thrombosis | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0000 events0 affected8,212 at risk
- EG0011 events1 affected8,280 at risk
|
| Venous thrombosis limb | Vascular disorders | MedDRA 15.1 | Systematic Assessment | | - EG0002 events1 affected8,212 at risk
- EG0010 events0 affected8,280 at risk
|